Matthews International Capital Management LLC Dr Reddys Laboratories LTD Transaction History

Matthews International Capital Management LLC

$589 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$62.12 - $74.2 $596,352 - $712,320	-9,600 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$57.98 - $73.08 $162,344 - $204,624	2,800 Added 41.18%	9,600 $589,000
Q4 2020 Feb 09, 2021	BUY	$62.61 - $71.29 $118,959 - $135,451	1,900 Added 38.78%	6,800 $485,000
Q3 2020 Nov 05, 2020	BUY	$51.39 - $72.41 $251,811 - $354,809	4,900 New	4,900 $341,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

Morgan Stanley New York, NY

2.24M
Shares

$34.5 Million
0.01% of portfolio
Robeco Institutional Asset Management B.V.

2.07M
Shares

$31.7 Million
0.33% of portfolio
Royal Bank Of Canada Toronto, A6

2M
Shares

$30.7 Million
0.03% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.95M
Shares

$30 Million
0.25% of portfolio
Black Rock Inc. New York, NY

1.8M
Shares

$27.7 Million
0.0% of portfolio

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account